Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo. (Q39245815)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

Joan Carles Escola-Gil

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Gemma Llaverias

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Cristina Andres-Lacueva

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Francisco Blanco-vaca

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Reija Silvennoinen

5

object named as

Reija Silvennoinen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Mireia Urpi-Sarda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Miriam Lee-Rueckert

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

161

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

110-117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23146569 AND SRC:MED&resulttype=core&format=json

17 February 2020

Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Anti-atherogenic effects of resveratrol

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol improves health and survival of mice on a high-calorie diet

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol regulates the expression of LXR-alpha in human macrophages

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

SirT1 gain of function increases energy efficiency and prevents diabetes in mice

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Distribution of Resveratrol Metabolites in Liver, Adipose Tissue, and Skeletal Muscle in Rats Fed Different Doses of This Polyphenol

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2012.10.008

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39245815&oldid=1744603019"